Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioAtla Inc.

    NASDAQ: BCAB · Real-Time Price · USD
    0.48
    -0.03 (-5.46%)
    At close: Jun 10, 2025, 3:59 PM

    BioAtla Statistics

    Share Statistics

    BioAtla has 58.42M shares outstanding. The number of shares has increased by 20.59% in one year.

    Shares Outstanding

    n/a
    		 58.42M

    Shares Change (YoY)

    n/a
    		 20.59%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 49.68%

    Shares Floating

    n/a
    		 44.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 748

    FTD / Avg. Volume

    n/a
    		 0.13%

    Short Selling Information

    The latest short interest is 4.34M, so 7.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.34M

    Short % of Shares Out

    n/a
    		 7.42%

    Short % of Float

    n/a
    		 8.33%

    Short Ratio (days to cover)

    n/a
    		 7.72

    Valuation Ratios

    The PE ratio is -0.41 and the forward PE ratio is -0.43. BioAtla's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.41

    Forward PE

    n/a
    		 -0.43

    PS Ratio

    n/a
    		 2.61

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 2.01

    P/FCF Ratio

    n/a
    		 -0.4

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioAtla.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 3.52

    Quick Ratio

    n/a
    		 3.52

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $180,327.87

    Profits Per Employee

    n/a
    		 $-1,143,868.85

    Employee Count

    n/a
    		 61

    Asset Turnover

    n/a
    		 0.21

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -66.67% in the last 52 weeks. The beta is 0.91, so BioAtla's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.91

    52-Week Price Change

    n/a
    		 -66.67%

    50-Day Moving Average

    n/a
    		 0.4

    200-Day Moving Average

    n/a
    		 1.01

    Relative Strength Index (RSI)

    n/a
    		 61

    Average Volume (20 Days)

    n/a
    		 556,642

    Income Statement

    In the last 12 months, BioAtla had revenue of 11M and earned -69.78M in profits. Earnings per share was -1.44.

    Revenue

    n/a
    		 11M

    Gross Profit

    n/a
    		 10.07M

    Operating Income

    n/a
    		 -73.94M

    Net Income

    n/a
    		 -69.78M

    EBITDA

    n/a
    		 -73.94M

    EBIT

    n/a
    		 -73.94M

    Earnings Per Share (EPS)

    n/a
    		 -1.44
    Full Income Statement

    Balance Sheet

    The company has 49.05M in cash and 836K in debt, giving a net cash position of 48.21M.

    Cash & Cash Equivalents

    n/a
    		 49.05M

    Total Debt

    n/a
    		 836K

    Net Cash

    n/a
    		 48.21M

    Retained Earnings

    n/a
    		 -486.04M

    Total Assets

    n/a
    		 38.29M

    Working Capital

    n/a
    		 21.53M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -71.94M and capital expenditures 0, giving a free cash flow of -71.94M.

    Operating Cash Flow

    n/a
    		 -71.94M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -71.94M

    FCF Per Share

    n/a
    		 -1.48
    Full Cash Flow Statement

    Margins

    Gross margin is 91.59%, with operating and profit margins of -672.21% and -634.33%.

    Gross Margin

    n/a
    		 91.59%

    Operating Margin

    n/a
    		 -672.21%

    Pretax Margin

    n/a
    		 -634.33%

    Profit Margin

    n/a
    		 -634.33%

    EBITDA Margin

    n/a
    		 -672.21%

    EBIT Margin

    n/a
    		 -672.21%

    FCF Margin

    n/a
    		 -653.96%

    Dividends & Yields

    BCAB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BCAB is $3, which is 500% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 500%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -22.81

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist